Search clinical trials for: AbobotulinumtoxinA (ABO)

Total 3359 results

AbbVie

Completed

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of ABT-493 and ABT-530 With and Without Ribavirin in Adults With HCV Who Failed a Prior DAA Containing Therapy

Chronic Hepatitis C | Hepatitis C Virus | HCV | Direct-Acting Antiviral Agent (DAA)-Experienced
University of Central Florida

Terminated

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Raynaud Phenomenon

United States
Emory University
Ipsen

Completed

Dysport for the Treatment of OMD

Tardive Dystonia | Oral Dystonia

United States
Assembly Biosciences

Completed

A First in Human Study to Assess Safety, Tolerability, Pharmacokinetics of ABI-4334 in Healthy Subjects

Chronic Hepatitis B

New Zealand
Assembly Biosciences

Completed

A Study of ABI-H2158 in Healthy Volunteers and Patients With Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of, Australia, United States, Hong Kong, United Kingdom, China, New Zealand
Abbott

Completed

Pharmacokinetic Study of ABT-126 in Stable Subjects With Schizophrenia

Schizophrenia

United States
University of California, San Francisco

Completed

Attachment and Biobehavioral Catch-up for Depression (ABC)

Depressive Symptoms | Anxiety Symptoms

United States
University of Tromso
University Hospital of North Norway; Public Health Sisters in the Tromsø municipality

Completed

The Northern Babies Longitudinal Study

Depression, Postpartum

Norway
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate Chronic Hepatitis C Infection

Chronic Hepatitis C Infection
Emory University
Ipsen

Suspended

Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A (CECS)

Compartment Syndrome of Leg

United States
Alexandria University

Active, not recruiting

Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars

Hypertrophic Scarring

Egypt
IUVO S.r.l.
Scuola Superiore Sant'Anna di Pisa; Össur Ehf

Recruiting

An Active Pelvis Orthosis (APO) for Post-stroke Gait Rehabilitation: a Pilot Study

Stroke

Italy
Capital Medical University

Recruiting

The Prehospital Administration of Normobaric Oxygen in Suspected Stroke (NO SUSPENSION)

Acute Stroke | Ischemic Stroke, Acute

China
University Hospital, Angers

Completed

VASO-AM :Impact of Oral Appliance Therapy on Endothelial Function in Obstructive Sleep Apnea (VASO-AM)

Obstructive Sleep Apnea Syndrome

France
University of Texas Southwestern Medical Center

Terminated

Effectiveness of Ankle Foot Orthoses on Gait in Multiple Sclerosis

Multiple Sclerosis

United States
AbbVie (prior sponsor, Abbott)

Completed

A Study to Evaluate Chronic Hepatitis C Infection in Treatment Experienced Adults

Chronic Hepatitis C Infection
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Using the Active Breathing Control Device to Reduce Radiation Side Effects to Critical Structures in Breast Cancer

Breast Cancer

United States
AbbVie

Completed

A Phase 2a Study Evaluating the Safety and Efficacy of ABT-981 in Patients With Erosive Hand Osteoarthritis

Erosive Hand Osteoarthritis
Abbott

Completed

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ABT-384 in Elderly Subjects

Healthy

United States
Johns Hopkins University

Recruiting

Dysport ® as an Adjunctive Treatment to Bracing in the Management of Adolescent Idiopathic Scoliosis

Adolescent Idiopathic Scoliosis

United States
AbbVie

Completed

A Study to Evaluate the Safety and Antiviral Effect of Multiple Doses of ABT-493 and ABT-530 in Adults With Genotype 1 Hepatitis C Virus (HCV)

Chronic Hepatitis C | Hepatitis C Virus | Compensated Cirrhosis
AbbVie

Completed

A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Chronic Hepatitis C | Hepatitis C Virus | HCV
Fundacion para la Investigacion Biomedica del Hospital...
MED-EL Elektromedizinische Geräte GesmbH

Recruiting

Anatomy-based Fitting in Cochear Implant Users

Quality of Life | Cochlear Implant | Outcomes

Spain
Harvard Medical School (HMS and HSDM)

Not yet recruiting

Evaluation and Management of Parturients' Pain Intensity

Labor Pain
AbbVie

Active, not recruiting

Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE)/Pibrentasvir (PIB)

Hepatitis C Virus (HCV)

United States, Australia, Austria, Canada, France, Germany, Italy, Spain
AbbVie (prior sponsor, Abbott)

Completed

Efficacy and Safety Study for Cognitive Deficits in Adult Subjects With Schizophrenia

Cognitive Deficits in Schizophrenia

United States
Terence Flotte
Massachusetts General Hospital; University of Massachusetts, Worcester

Active, not recruiting

A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease

Tay-Sachs Disease | Sandhoff Disease

United States
Fundació Sant Joan de Déu

Recruiting

Effects of the Postbiotic Blend ABB C3 on Adiposity and Glucose Metabolism in Children and Adolescents (PostOb)

Obesity, Childhood | Obesity, Adolescent

Spain
Assembly Biosciences

Completed

A Study to Assess the Relative Bioavailability and Food Effect of ABI-H2158 in Healthy Adults

Chronic Hepatitis B

United States
Cairo University

Unknown

Ridge Preservation In Mandibular Molars Using Mixture Of ABB And Autogenous Particulate VS Sticky Bone

Alveolar Bone Loss | Alveolar Bone Resorption | Bone Graft Failure
AbbVie (prior sponsor, Abbott)

Completed

An Evaluation of the Biodistribution and Imaging Characteristics of ABT-806i (111In-ABT-806) in Subjects With Advanced Solid Tumor Types

Advanced Solid Tumors

Australia
Istituto Scientifico Romagnolo per lo Studio e...

Recruiting

Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. (HBO-RT)

High Grade Glioma | Malignant Glioma | Recurrent Glioma

Italy
Mario Negri Institute for Pharmacological Research
Bayer

Completed

Peripheral Artery Disease in Patients With Stable Coronary Artery Disease in General Practice: Prevalence, Management and Clinical Outcomes. (PAD&CAD)

Peripheral Artery Disease

Italy
Arrowhead Pharmaceuticals

Active, not recruiting

Study of ARO-APOC3 in Adults With Dyslipidemia

Dyslipidemias

United States, Australia, Canada, Poland, Netherlands, New Zealand, Hungary
Universidad Rey Juan Carlos

Completed

Attentional Bias Modification in Fibromyalgia Patients (ABM) (ABM)

Fibromyalgia

Spain
University of Manchester

Completed

Healthy Eating and Active Lifestyle After Bowel Cancer: HEAL ABC (HEALABC)

Colorectal Cancer | Survivorship | Behavior, Health

United Kingdom
Arrowhead Pharmaceuticals

Completed

Study of ARO-HIF2 in Patients With Advanced Clear Cell Renal Cell Carcinoma

Clear Cell Renal Cell Carcinoma

United States
ID3 Medical
CyndRx, LLC

Completed

AbsorbaSeal (ABS 5.6.7) Vascular Closure Device Trial

Peripheral Arterial Disease

Belgium
AbbVie (prior sponsor, Abbott)

Terminated

This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's Disease

Alzheimer's Disease

United States, Poland, Russian Federation, South Africa, Ukraine, United Kingdom
Antiva Biosciences

Completed

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

HIV Infection | Anal Cancer | Anus Neoplasms | Human Papilloma Virus Infection | HSIL, High-Grade Squamous Intraepithelial Lesions

United States, Australia
AbbVie

Terminated

Long-term Safety and Efficacy of ABT-126 in Subjects With Schizophrenia: An Extension Study for Subjects Completing Study M10-855 (NCT01655680)

Schizophrenia

United States, Russian Federation, United Kingdom
AbbVie (prior sponsor, Abbott)

Completed

Study of ABT-767 in Subjects With Breast Cancer 1 and Breast Cancer 2 (BRCA 1 and BRCA 2) Mutations and Solid Tumors or High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Primary Peritoneal Cancer | Fallopian Tube | Solid Tumors (e.g. Breast, Ovarian, Prostate, or Pancreatic) and Ovarian

Netherlands
AbbVie

Terminated

[11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis

Multiple Sclerosis

United Kingdom
AbbVie (prior sponsor, Abbott)

Completed

An Extension Study of ABT-806 in Subjects With Advanced Solid Tumors

Advanced Solid Tumors

United States, Australia
St. Jude Children's Research Hospital

Terminated

The Effects of Ankle Foot Orthoses on Gait Efficiency in Children With Acute Lymphoblastic Leukemia and Foot Drop

Acute Lymphoblastic Leukemia | Foot Drop

United States
AbbVie

Completed

Bioavailability of ABT-333 Within the Gastrointestinal Tract in Healthy Subjects

Relative Bioavailability

United Kingdom
AbbVie (prior sponsor, Abbott)

Completed

A Follow-up Study to Assess Resistance to ABT-072 in HCV-infected Subjects Administered ABT-072 in Prior ABT-072 Studies

Hepatitis C Virus Infection

United States
AbbVie (prior sponsor, Abbott)

Completed

A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD)

Attention Deficit Hyperactivity Disorder

United States
Abbott

Terminated

A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

Alzheimer's Disease

United States
Amgen

Completed

ABX-EGF as Second Line Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)

Neoplasm Metastasis | Lung Cancer | Non-small Cell Lung Cancer

3

Subscribe